About 350 people joined the American Lung Association today for the “Fight for Air” climb inside Kansas City’s tallest skyscraper, supporting the more than 400,000 people in ...

As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...

Paediatric patients have a wide age range, a high proportion of acute diseases, insidious clinical manifestations with the ...

Respiratory illnesses are on the rise in Louisiana, according to the state Department of Health’s dashboard.

The trials in breast, lung, and colorectal cancer, supported by ARPA-H, will focus on guiding decisions across different lines of therapy using serial biopsies and tumor profiling.

The approval was based on a cohort of treatment-naïve patients in the Beamion LUNG-1 trial who had unresectable or metastatic, non-squamous NSCLC with HER2 tyrosine kinase domain mutations.

The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior ...

Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Alzheimer’s disease is one of the most feared illnesses of aging. It slowly destroys memory, thinking ability, and independence. For many years, scientists have focused on abnormal proteins in the ...

The FDA has granted accelerated approval to zongertinib (Hernexeos) for the treatment of adults with unresectable or ...

The U.S. Food and Drug Administration (FDA) has approved Hernexeos (zongertinib) for adults with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have specific HER2 ...